Clinical Features and Risk Factors of Rapidly Progressive Systemic Sclerosis in a Single Center in China: Anti-RNA Polymerase III Antibodies as a Predictor

被引:1
|
作者
Yu, Qiuxia [1 ,2 ]
Zhang, Jin [1 ,2 ]
Fan, Liyi [3 ]
Yu, Tianhang [3 ]
Liu, Bingbing [1 ,2 ]
Ding, Jian [1 ,2 ]
机构
[1] Lihuili Hosp, Ningbo Med Ctr, Dept Rheumatol & Clin Immunol, Ningbo 315040, Zhejiang, Peoples R China
[2] Ningbo Univ, Li Huili Hosp, Dept Rheumatol & Clin Immunol, Ningbo 315040, Zhejiang, Peoples R China
[3] Ningbo Univ, Sch Med, Ningbo 315211, Zhejiang, Peoples R China
关键词
rapidly progressive systemic sclerosis; clinical characteristics; predictors; anti-RNA polymerase III antibodies; malignancy; AUTOANTIBODIES; INVOLVEMENT;
D O I
10.24976/Discov.Med.202335175.20
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objectives: Systemic sclerosis (SSc) have been classified in two clinical subsets (diffuse and limited) based on the extend of skin thickening. In this study, we classified a novel subset of SSc defined rapidly progressive systemic sclerosis (RPSSc), which based on the rate of skin thickening progression and the progressive of interstitial lung disease (ILD). We aimed to evaluate RPSSc clinical characteristics and predictive factors in a Chinese single center. Method: Overall, 75 patients diagnosed with SSc, classified into RPSSc (n = 14) and non-rapidly progressive SSc (non-RPSSc, n = 61) were retrospectively included in the study. Clinical characteristics, disease severity and autoantibodies were collected. Logistic regression, least absolute shrinkage, and selection operator (LASSO) regression analysis was used to identify RPSSc predictors. Receiver operating characteristic (ROC) analysis and Delong test was conducted to evaluate and compare different indexes.Results: RPSSc rate was 18.7%. ILD (64.3%), cardiac involvement (42.9%) were the most common organ system involvement of RPSSc, while Raynaud's phenomenon incidence significantly decreased. Disease duration (12 vs 72, months), sex (42.9% vs 11.5%, male %), SSc subset (85.7% vs 27.9%, diffuse cutaneous SSc (dsSSc) %), modified Rodnan total skin score (mRSS) (20.5 vs 6), Raynaud's phenomenon (64.3% vs 98.4%), cardiac involvement (42.9% vs 18%), higher incidence with malignancy (28.6% vs 1.6%) and positive anti-RNA polymerase III antibodies (ARA) (64.3% vs 1.6%) were statistically significant differences among the RPSSc groups and non-RPSSc groups (p < 0.05). Univariate analysis showed that positive ARA, male, dsSSc and malignancy were RPSSc risk factors, while long-disease duration, Raynaud's phenomenon was RPSSc protective factors. ARA was the strongest factor associated to RPSSc (OR 108, 95% CI 11.287-1033.327, p < 0.001). LASSO logistic regression model identified six factors: Disease duration, dsSSc, malignancy, cardiac involvement, positivity of ARA were RPSSc risk factors, Raynaud's phenomenon was RPSSc protective factors.Conclusions: RPSSc is an SSc clinical category which should be accounted for early detection of organ involvement and close follow-up of malignancy. ARA might be used as a predictor for RPSSc and organ involvement.
引用
收藏
页码:193 / 200
页数:8
相关论文
共 50 条
  • [41] Increased apoptosis in circulating lymphocyte cultures of anti-RNA polymerase III positive patients with systemic sclerosis
    Majone, Franca
    Olivieri, Silvia
    Cozzi, Franco
    Montaldi, Anna
    Tonello, Marta
    Visentin, Maria Serena
    Ciprian, Luca
    Ruffatti, Amelia
    RHEUMATOLOGY INTERNATIONAL, 2009, 29 (08) : 891 - 895
  • [42] Increased Frequency of Malignancies Synchronous to the Onset of Systemic Sclerosis in Anti-RNA Polymerase III Antibodies Positive Patients: A Eustar Multicentre Study
    Lazzaroni, Maria Grazia
    Colombo, Enrico
    Cavazzana, Ilaria
    Distler, Oliver
    Dobrota, Rucsandra
    Eisenring, Jasmin
    Hesselstrand, Roger
    Czirjak, Lazlo
    Varju, Cecilia
    Nagy, Gabriella
    Smith, Vanessa
    Caramaschi, Paola
    Riccieri, Valeria
    Hachulla, Eric
    Romanowska-Prochnicka, Katarzyna
    Balbir-Gurman, Alexandra
    Chatelus, Emmanuel
    Araujo, Ana Carolina
    Allanore, Yannick
    Airo, Paolo
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [43] ASSOCIATION OF ANTI-RNA POLYMERASE III ANTIBODY AND BREAST IMPLANTS RUPTURE IN ITALIAN PATIENTS WITH SYSTEMIC SCLEROSIS
    Lazzaroni, Maria Grazia
    Caimmi, Cristian
    Bertoldo, Eugenia
    Franceschini, Franco
    Tincani, Angela
    Airo, Paolo
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1795 - 1795
  • [44] Presence of Anti-RNA Polymerase 3 Antibody in Systemic Sclerosis, Renal Disease, Malignancy and ILD from a Single Academic Center Cohort
    Kirkpatrick, Matthew
    Lee, Janet
    Tebo, Anne
    Li, Haojia
    Zhang, Yue
    Frech, Tracy
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 2880 - 2882
  • [45] Enzyme-linked immunosorbent assay for detection of anti-RNA polymerase III antibody - Analytical accuracy and clinical associations in systemic sclerosis
    Kuwana, M
    Okano, Y
    Pandey, JP
    Silver, RM
    Fertig, N
    Medsger, TA
    ARTHRITIS AND RHEUMATISM, 2005, 52 (08): : 2425 - 2432
  • [46] Prevalence of Anti-RNA Polymerase III Antibodies in Systemic Sclerosis New Data From a French Cohort and a Systematic Review and Meta-Analysis
    Sobanski, Vincent
    Dauchet, Luc
    Lefevre, Guillaume
    Lambert, Marc
    Morell-Dubois, Sandrine
    Sy, Thierno
    Hachulla, Eric
    Hatron, Pierre-Yves
    Launay, David
    Dubucquoi, Sylvain
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 (02) : 407 - 417
  • [47] Case of systemic sclerosis with multiple primary malignancies in whom anti-RNA polymerase III antibody was detected by immunoprecipitation
    Aozasa, Naohiko
    Miyazaki, Miki
    Hayakawa, Jun
    Tamaki, Takeshi
    Hamaguchi, Yasuhito
    Sato, Shinichi
    Asano, Yoshihide
    JOURNAL OF DERMATOLOGY, 2020, 47 (07): : E269 - E270
  • [48] Anti-RNA polymerase III antibodies: A marker of systemic sclerosis with rapid onset and skin thickening progression (vol 8, pg 580, 2009)
    Cavazzana, Ilaria
    Ceribelli, Angela
    Airo, Paolo
    Zingarelli, Stefania
    Tincani, Angela
    Franceschini, Franco
    AUTOIMMUNITY REVIEWS, 2013, 12 (03) : 457 - 457
  • [49] PREVALENCE OF ANTI-RNA POLYMERASE III ANTIBODIES IN SYSTEMIC SCLEROSIS: NEW DATA FROM A FRENCH COHORT, SYSTEMATIC REVIEW AND META-ANALYSIS
    Sobanski, V.
    Dauchet, L.
    Lefere, G.
    Lambert, M.
    Morell-Dubois, S.
    Sy, T.
    Hachulla, E.
    Hatron, P. Y.
    Launay, D.
    Dubucquoi, S.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (02) : S66 - S66
  • [50] Malignancies in Patients with Anti-RNA Polymerase III Antibodies and Systemic Sclerosis: Analysis of the EULAR Scleroderma Trials and Research Cohort and Possible Recommendations for Screening
    Lazzaroni, Maria-Grazia
    Cavazzana, Ilaria
    Colombo, Enrico
    Dobrota, Rucsandra
    Hernandez, Jasmin
    Hesselstrand, Roger
    Varju, Cecilia
    Nagy, Gabriella
    Smith, Vanessa
    Caramaschi, Paola
    Riccieri, Valeria
    Hachulla, Eric
    Balbir-Gurman, Alexandra
    Chatelus, Emmanuel
    Romanowska-Prochnicka, Katarzyna
    Araujo, Ana Carolina
    Distler, Oliver
    Allanore, Yannick
    Airo, Paolo
    JOURNAL OF RHEUMATOLOGY, 2017, 44 (05) : 639 - 647